- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 10, 2024
Discovery & Translation
Science spotlight: Moonlight’s enhanced T cells; plus a HUNK inhibitor and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 9, 2023
Discovery & Translation
Two metabolites that inhibit Th17 differentiation for MS; plus Cirius’ MPC inhibitor for COVID-19 and more
BioCentury’s roundup of translational news
BioCentury | Oct 29, 2021
Discovery & Translation
Omics-based target identification in UK Biobank and COVID-19 cohorts
Plus: technologies from Harvard, Texas A&M, Disney lab and more
BioCentury | Sep 15, 2016
Distillery Therapeutics
Therapeutics: Activator protein-1 (AP-1; JUN); CDK5 regulatory subunit associated protein 1 (CDK5RAP1)
BioCentury | Feb 18, 2013
Company News
Phylogica, Bio-Link Australia Pty. Ltd. inflammation, pulmonary news
Items per page:
1 - 10 of 18